Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer—what limits limited disease?
Authors:
- Patrick MickePatrick Micke
- Andreas FaldumAFAndreas Faldum
- Tsegay MetzTMTsegay Metz
- Kai-Michael BeehKBKai-Michael Beeh
- Fernando BittingerFBFernando Bittinger
- Jan-Georg HengstlerJan-Georg Hengstler
- Roland BuhlRBRoland Buhl
- 1 September 2002
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 37 (3) , 271-276
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994British Journal of Cancer, 2001
- New Combinations in the Treatment of Lung CancerChest, 2000
- Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and EtoposideNew England Journal of Medicine, 1999
- Small Cell Lung CancerChest, 1997
- Initial Chemotherapeutic Doses and Survival in Patients with Limited Small-Cell Lung CancerNew England Journal of Medicine, 1993
- A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung CancerNew England Journal of Medicine, 1992
- Staging and prognostic factors in small cell lung cancer: a consensus reportLung Cancer, 1989
- Pretreatment prognostic factors and scoring system in 407 small‐cell lung cancer patientsInternational Journal of Cancer, 1987
- A New International Staging System for Lung CancerChest, 1986
- Isolated Pleural Effusion in Small Cell Lung Carcinoma: Favorable PrognosisChest, 1982